ABVC BioPharma, Inc. (NASDAQ:ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that, on August 2, 2022, approval was
BEIJING, Aug. 18, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ:WETG), an emerging growth company engaged in the business of providing software-as-a-services
New clinical data demonstrate high and sustained geometric mean fold rises (GMFR) in neutralizing antibodies against all evaluated Omicron variants
Six months after booster dose of ARCT-154:
BA.1: GMFR = 22 to 52;
Science 37 Holdings, Inc. (NASDAQ:SNCE), the Agile Clinical Trial Operating System™, and Syapse®, a leading real-world evidence company, today announced a partnership to deploy proprietary real-world data
Trial is the first randomized, controlled clinical trial evaluating cannabidiol to treat children and adolescents living with a developmental and epileptic encephalopathy known as Epilepsy with
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Saudi Food and Drug Authority (SFDA) has approved oral, once-daily ORLADEYO® (berotralstat) to prevent attacks of hereditary
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, has announced the start of enrollment in a first-in-human trial of a peripheral sirolimus drug-coated balloon (DCB).
BD is a
Former Vice President Mike Pence said he would consider testifying before the Jan. 6 select committee investigating the riots on Capitol Hill and the role played by former President Donald Trump in the events leading up to the insurrection — if he was invited to participate.